Detail for CD44+/CD24- BCSC

Full Name

CD44+/CD24- Breast cancer stem cells

Gene Name


Related Disease

  • Breast cancer [ref.1]

Therapy Method


The CD44+/CD24- subpopulation was believed to be putative stem cells in human breast tissue, enriched for basal cells and motility genes, which could be generated during the epithelial-mesenchymal transition. Moreover, these cells were negative for mucin 1, estrogen receptor (ER), and v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 (erbB2) receptor. More importantly, high expression of CD44+/CD24- cancer cells was associated with poor patient prognosis. These cells had the phenotype of cancer cells during the epithelial to mesenchymal transition, indicating that the gene expression pattern of CD44+/CD24- cells in breast cancers resembled more closely the pattern observed in CD44+/CD24- cells in normal breast than that of CD44-/CD24+ cells isolated from the same tumor. Taken together, these findings indicated that CD44+/CD24- cells, especially those expressing epithelial cell adhesion molecule, were breast cancer stem cells (CSCs).

Related Pathway/CSCs feature

  • Not Detected


  • [1] Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer.
    Seo, A. N., et al. (2013). Br J Cancer 109(10): 2705-2713. [ 24129232 ]

Back to top